Home > Insider Trading > Filing (0001654954-20-000265)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1540159	Edesa Biotech Inc.	EDSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1779126	J Michael Brooks	C/O Edesa Biotech Inc. 100 Spy Court Markham A6 L3R 5H6	President	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2020-01-08	1,827	$4.11	1,827	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Shares	Common Share Warrants (Right to Buy)	Acquisiton	2020-01-08	1,371	$0.00	1,371	$4.80
Common Shares	Common Share Warrants (Right to Buy)	Acquisiton	2020-01-08	914	$0.00	914	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,371	2020-07-08	2023-07-08	No	4	P	Direct
914	2020-07-08	2020-11-08	No	4	P	Direct

Footnotes

The reported securities are included within 1,371 Common Shares purchased by the reporting person for $4.11 per Common Share. Each Common Share includes the purchase of Class A Warrants to purchase 0.75 of a Common Share, and Class B Warrants to purchase 0.50 of a Common Share.
Consists of Class A Warrants to purchase Common Shares. The Class A Warrants are exercisable beginning on July 8, 2020 and expire on July 8, 2023.
Consists of Class B Warrants to purchase Common Shares. The Class B Warrants are exercisable beginning on July 8, 2020 and expire on November 8, 2020.